CASI Pharmaceuticals (CASI) Stock Highlights

2.65 | -1.49%

2024-12-21 06:58:38

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA. The company primarily operates in the United States, Canada, China and other parts of the world.

Statistics

Range Today

2.65 2.82

Volume Today 76.9K

Range 1 Year

2.05 8.19

Volume 1 Year 32.52M

Range 3 Year

1.45 10.3

Volume 3 Year 65.61M

Range 10 Year

1.45 88.9

Volume 10 Year 140.58M

Highlights

Market Capitalization 84.74M (small)

Floating Shares 5.95M

Current Price 2.65

Price To Earnings -2.8

Price To Revenue 3.46

Price To Book 8.22

Earnings Per Share -2.03

Payout Ratio 0%

Performance

Latest -1.49%

1 Month -50.56%

3 Months -59.67%

6 Months -2.93%

1 Year -63.95%

3 Years -68.45%

5 Years -91.72%

10 Years -78.28%

Benchmarks

Market Capitalization

279 / 368

Gross Profits

0 / 278

Total Revenue

132 / 300

Total Rank

20 / 368

Free Cashflow

0 / 352

Performance 5 years

283 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.